Balaxi Pharmaceuticals reports continued solid growth in Q3FY22
– PAT improves by 18% YoY for Q9MFY22 – Revenue for the Pharmaceuticals grows by 31% in Q3FY22, with strong
Read More– PAT improves by 18% YoY for Q9MFY22 – Revenue for the Pharmaceuticals grows by 31% in Q3FY22, with strong
Read More